scholarly journals Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy

2017 ◽  
Vol 110 (5) ◽  
pp. 460-466 ◽  
Author(s):  
Daniel Delitto ◽  
Thomas J George ◽  
Tyler J Loftus ◽  
Peihua Qiu ◽  
George J Chang ◽  
...  
2011 ◽  
Vol 29 (1) ◽  
pp. 168-173 ◽  
Author(s):  
Hongjiang Yan ◽  
Jinming Yu ◽  
Renben Wang ◽  
Shumei Jiang ◽  
Kunli Zhu ◽  
...  

Author(s):  
Claudia Reali ◽  
Gabriele Bocca ◽  
Ian Lindsey ◽  
Oliver Jones ◽  
Chris Cunningham ◽  
...  

AbstractAccurate preoperative staging of colorectal cancers is critical in selecting patients for neoadjuvant therapy prior to resection. Inaccurate staging, particularly understaging, may lead to involved resection margins and poor oncological outcomes. Our aim is to determine preoperative imaging accuracy of colorectal cancers compared to histopathology and define the effect of inaccurate staging on patient selection for neoadjuvant treatment(NT). Staging and treatment were determined for patients undergoing colorectal resections for adenocarcinomas in a single tertiary centre(2016–2020). Data were obtained for 948 patients. The staging was correct for both T and N stage in 19.68% of colon cancer patients. T stage was under-staged in 18.58%. At resection, 23 patients (3.36%) had involved pathological margins; only 7 of which had been predicted by pre-operative staging. However, the staging was correct for both T and N stage in 53.85% of rectal cancer patients. T stage was understaged in 26.89%. Thirteen patients had involved(R1)margins; T4 had been accurately predicted in all of these cases. There was a general trend in understaging both the tumor and lymphonodal involvement (T p < 0.00001 N p < 0.00001) causing a failure in administrating NT in 0.1% of patients with colon tumor, but not with rectal cancer. Preoperative radiological staging tended to understage both colonic and rectal cancers. In colonic tumours this may lead to a misled opportunity to treat with neoadjuvant therapy, resulting in involved margins at resection.


Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 516
Author(s):  
Daan Linders ◽  
Marion Deken ◽  
Maxime van der Valk ◽  
Willemieke Tummers ◽  
Shadhvi Bhairosingh ◽  
...  

Rectal cancer patients with a complete response after neoadjuvant therapy can be monitored with a watch-and-wait strategy. However, regrowth rates indicate that identification of patients with a pathological complete response (pCR) remains challenging. Targeted near-infrared fluorescence endoscopy is a potential tool to improve response evaluation. Promising tumor targets include carcinoembryonic antigen (CEA), epithelial cell adhesion molecule (EpCAM), integrin αvβ6, and urokinase-type plasminogen activator receptor (uPAR). To investigate the applicability of these targets, we analyzed protein expression by immunohistochemistry and quantified these by a total immunostaining score (TIS) in tissue of rectal cancer patients with a pCR. CEA, EpCAM, αvβ6, and uPAR expression in the diagnostic biopsy was high (TIS > 6) in, respectively, 100%, 100%, 33%, and 46% of cases. CEA and EpCAM expressions were significantly higher in the diagnostic biopsy compared with the corresponding tumor bed (p < 0.01). CEA, EpCAM, αvβ6, and uPAR expressions were low (TIS < 6) in the tumor bed in, respectively, 93%, 95%, 85%, and 62.5% of cases. Immunohistochemical evaluation shows that CEA and EpCAM could be suitable targets for response evaluation after neoadjuvant treatment, since expression of these targets in the primary tumor bed is low compared with the diagnostic biopsy and adjacent pre-existent rectal mucosa in more than 90% of patients with a pCR.


2020 ◽  
Vol 26 (42) ◽  
pp. 6638-6657
Author(s):  
Fang-Ze Wei ◽  
Shi-Wen Mei ◽  
Jia-Nan Chen ◽  
Zhi-Jie Wang ◽  
Hai-Yu Shen ◽  
...  

2009 ◽  
Vol 16 (10) ◽  
pp. 2771-2778 ◽  
Author(s):  
Jeong Yeon Kim ◽  
Nam Kyu Kim ◽  
Seung Kook Sohn ◽  
Yong Wan Kim ◽  
Kim Jin Soo Kim ◽  
...  

2019 ◽  
Vol 23 (4) ◽  
pp. 333-342 ◽  
Author(s):  
A. H. Şirin ◽  
S. Sökmen ◽  
S. M. Ünlü ◽  
H. Ellidokuz ◽  
S. Sarioğlu

Sign in / Sign up

Export Citation Format

Share Document